Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

HEL/FARON stock hub

HEL/FARON has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

HEL/FARONis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

97M

Nasdaq Helsinki

Market data

Price

Recent price action with selectable time range.

HEL/FARONHEL/FARON

—

Loading chart…

In the news

Latest news · HEL/FARON

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC-297.2

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All HEL/FARON market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

134

Groups with data

Currency

EUR

Showing 134 of 134 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Finland
Country code	FI
Employees	33
Employees Change	7%
Employees Change Percent	28
Enterprise value	EUR 109.5M
Exchange	Nasdaq Helsinki
Financial currency	EUR
First seen	2026-05-10
Industry	Biotechnology
Last refreshed	2026-05-10
Market cap	EUR 97M
Price	EUR 0.48
Price currency	EUR
Sector	Healthcare
Sic	2834
Symbol	hel/FARON
Website	https://faron.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-28.1%
EV Earnings	-4.02x
P/B ratio	-5.24x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	EUR -27.3M
Profit Per Employee	EUR -825,970
ROA	-85.32
Roa5y	-123.4
ROCE	1,190.8
ROIC	-297.2

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-80.33%
Cagr3y	-44.52%
Cagr5y	-31.43%

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	EUR 17.2M
Cash	EUR 12.3M
Current Assets	EUR 15.8M
Current Liabilities	EUR 18.9M
Debt	EUR 24.7M
Equity	EUR -18.5M
Interest Coverage	-15.96
Liabilities	EUR 35.7M
Long Term Assets	EUR 1.3M
Long Term Liabilities	EUR 16.8M
Net Cash	EUR -12.4M
Net Cash By Market Cap	EUR -12.74
Tangible Book Value	EUR -19.6M
Tangible Book Value Per Share	EUR -0.17
WACC	9.07

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.84
Net Working Capital	EUR -5M
Quick ratio	0.68
Working Capital	EUR -3M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-26.21%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-80.31%
200-day SMA	1.67
3Y total return	-82.93%
50-day SMA	0.52
50-day SMA vs 200-day SMA	50under200
5Y total return	-84.84%
All Time High	12.5
All Time High Change	-96.14%
All Time High Date	2020-03-20
All Time Low	0.44
All Time Low Change	10.65%
All Time Low Date	2026-04-10
ATR	0.03
Beta	1.11
Ch YTD	-76.78
High	0.49
High52	3.35
High52 Date	2025-05-30
High52ch	-85.74%
Low	0.47
Low52	0.44
Low52 Date	2026-04-10
Low52ch	9.28%
Ma50ch	-7.67%
Price vs 200-day SMA	-71.11%
RSI	41.93
RSI Monthly	34.08
RSI Weekly	22.54
Sharpe ratio	-1.21x
Sortino ratio	-1.38
Total Return	-26.21%
Tr YTD	-76.14
Tr1m	-13.13%
Tr1w	-2.33%
Tr3m	-74.12%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -20.3M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	153,695,050%
Net Borrowing	15,969,000
Shares Insiders	9.39%
Shares Institutions	2.81%
Shares Qo Q	8.03%
Shares Yo Y	26.21%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	1,086,153.05x
Bv Per Share	-0.16
Ch1m	-13.13
Ch1w	-2.33
Ch1y	-80.83
Ch3m	-74.82
Ch3y	-86.2
Ch5y	-87.74
Ch6m	-78.53
Change	-1.24%
Change From Open	-1.45
Close	0.48
Days Gap	0.21
Depreciation Amortization	219,000
Dollar Volume	124,235.6
Earnings Date	2026-08-26
EBIT	EUR -20.3M
EBITDA	EUR -20M
EPS	EUR -0.24
F Score	2
Financing CF	20,644,000
Fiscal Year End	December
Founded	2,003
Income Tax	EUR 2,000
Investing CF	-20,000
Is Primary Listing	0
Last Earnings Date	2026-03-04
Last Report Date	2025-12-31
Ma150	1.46
Ma150ch	-66.83%
Ma20	0.48
Ma20ch	0.96%
Net CF	2,814,000
Next Earnings Date	2026-08-26
Open	0.48
Position In Range	28.57
Ppne	189,000
Price Date	2026-05-08
Relative Volume	0.24x
Share Based Comp	1,822,000
Tr6m	-77.94%
Volume	260,452

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does HEL/FARON pay a dividend?

Capital-return profile for this ticker.

Performance

HEL/FARON stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns HEL/FARON?

Insider, institutional, and short-interest positioning.

Institutional ownership

+2.8%

Share of float held by funds and institutions

Insider ownership

+9.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+26.2%

Negative means the company is buying back shares.

Technical

HEL/FARON momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

41.9

Neutral momentum band

Price vs 200-day MA

-71.1%

50/200-day relationship not available

Beta (5Y)

1.11

Moves roughly with the market

Sharpe ratio

-1.21

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About HEL/FARON

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hel/FARON stock rating?

hel/FARON is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hel/FARON analysis?

The full report lives at /stocks/hel/FARON/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hel/FARON?

The latest report frames hel/FARON around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hel/FARON page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.